LEUKOCYTE COUNT, PROTEINURIA AND SMOKING IN TYPE-1 DIABETES-MELLITUS

被引:0
|
作者
MUHLHAUSER, I
VERHASSELT, R
SAWICKI, PT
BERGER, M
机构
关键词
LEUKOCYTES; NEPHROPATHY; SMOKING;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A case-control study was carried out to analyse leucocyte counts in relation to proteinuria and smoking in type 1 (insulin-dependent) diabetes. The subjects were 180 smoking (87 women, age 32 +/- 11 years, diabetes duration 14 +/- 6 years) and 188 nonsmoking (88 women, age 32 +/- 11 years, diabetes duration, 14 +/- 6 years) type 1 diabetic patients. Leucocyte counts were higher in smokers than in nonsmokers, both in women (7.6 +/- 2.3 vs 6.8 +/- 1.9 x 10(9)/l, P < 0.01) and in men (8.1 +/- 2.7 vs 6.4 +/- 2.0 x 10(9)/l, P < 0.0001). Leucocyte counts correlated with the number of cigarettes smoked per day (r = 0.32, P < 0.0001), but were unrelated to glycosylated haemoglobin levels. Among nonsmokers, leucocyte counts were comparable between patients with no mal proteinuria (6.7 +/- 2.2 x 10(9)/l, n = 106), microproteinuria (6.3 +/- 1.7 x 10(9)/l, n = 66) and macroproteinuria (6.8 +/- 1.1 x 10(9)/l, n = 16). Among smokers, patients with macroproteinuria or microproteinuria had higher leucocyte counts than those with normal proteinuria [8.9 + 3.0 x 10(9)/l, (n = 36) vs 8.4 + 2.7 x 10(9)/l (n = 61) vs 7.0 + 1.9 x 10(9)/l (n = 83); P < 0.0001)], a finding which was not due to differences in the number of cigarettes smoked per day. It is concluded that in these type 1 diabetic patients leucocyte counts were higher in smokers than in nonsmokers. Among nonsmokers leucocyte counts were comparable between patients with normal proteinuria and increased proteinuria, whereas among smokers leucocyte counts were higher in patients with increased proteinuria. It appears it would be worthwhile examining in prospective studies whether leucocyte counts can contribute to identifying those type 1 diabetic patients with a particularly high risk of cardiovascular complications.
引用
收藏
页码:105 / 107
页数:3
相关论文
共 50 条
  • [31] TYPE-1 DIABETES-MELLITUS AND HOMOCYST(E)INE
    ROBILLON, JF
    CANIVET, B
    CANDITO, M
    SADOUL, JL
    JULLIEN, D
    MORAND, P
    CHAMBON, P
    FREYCHET, P
    DIABETES & METABOLISM, 1994, 20 (05): : 494 - 496
  • [32] STUDY OF ERYTHROCYTE DEFORMABILITY IN TYPE-1 DIABETES-MELLITUS
    SANCHEZGABRIEL, JAG
    SAENZ, SG
    GARCIA, JAV
    MEDICINA CLINICA, 1985, 85 (20): : 827 - 830
  • [33] GLUCOCORTICOID RECEPTORS IN MONOCYTES IN TYPE-1 DIABETES-MELLITUS
    DAMM, P
    BINDER, C
    CLINICA CHIMICA ACTA, 1989, 184 (02) : 167 - 174
  • [34] PROTEINURIA IN DIABETES-MELLITUS
    BRATUSCHMARRAIN, P
    ACTA MEDICA AUSTRIACA, 1988, 15 (01) : 12 - 14
  • [35] THE DIRECT COST OF TYPE-1 DIABETES-MELLITUS IN ISRAEL
    STERN, Z
    LEVY, R
    DIABETIC MEDICINE, 1994, 11 (06) : 528 - 533
  • [36] DEFECTIVE AUTOLOGOUS MIXED LEUKOCYTE REACTION (AMLR) IN NEWLY DIAGNOSED TYPE-1 DIABETES-MELLITUS (IDDM)
    RASANEN, L
    HYOTY, H
    HUUPPONEN, T
    LEINIKKI, P
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (03) : 326 - 326
  • [37] IMMUNOLOGICAL ASPECTS OF TYPE-1 AND TYPE-2 DIABETES-MELLITUS
    LERNMARK, A
    BAEKKESKOV, S
    GERLING, I
    KASTERN, W
    KNUTSON, C
    MICHELSEN, B
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 189 : 107 - 127
  • [38] APOLIPOPROTEIN(A) LEVELS IN TYPE-1 AND TYPE-2 DIABETES-MELLITUS
    RUOTOLO, G
    ZOPPO, A
    PARLAVECCHIA, M
    GIBERTI, B
    MICOSSI, P
    ACTA DIABETOLOGICA, 1991, 28 (02) : 158 - 161
  • [39] GRANULOCYTIC FUNCTION IN DIABETES-MELLITUS TYPE-1 AND TYPE-2
    PERSCHEL, WT
    YILDIZ, M
    FEDERLIN, K
    IMMUNITAT UND INFEKTION, 1994, 22 (06): : 222 - 226
  • [40] A NORMAL EXERCISE RESPONSE IN UNCOMPLICATED TYPE-1 DIABETES-MELLITUS
    KELLEHER, C
    FERRISS, JB
    ROSS, H
    OSULLIVAN, DJ
    CLINICAL SCIENCE, 1986, 71 : P61 - P62